---
title: "Diagnosis of hepatocellular carcinoma"
date: "2023-02-08"
enableToc: false
---

> [!info]
>
> ðŸŒ± ä¾†è‡ª: [[hepatocellular carcinoma]]

# Diagnosis of hepatocellular carcinoma

- Can diagnose w/o biopsy in high-risk Pts with 3-phase contrast CT or MRI
- Only 15% of liver masses are HCC; liver metastases from other 1Â° more common
- ***

![Figure: Natural history, impact of therapies, and unmet needs in hepatocellular carcinoma (HCC). AFP, Î± fetoprotein; ECOG, Eastern Cooperative Oncology Group performance status; mAb, monoclonal antibody; TACE, transarterial chemoembolization; TKI, tyrosine kinase inhibitor.](https://i.imgur.com/TtTSnNg.png)

---

| Stage | EcoG | Child-Pugh |
| ----- | ---- | ---------- |
| 0     | 0    | A          |
| A-C   | 0    | A/B        |
| D     | 3-4  | C          |

## Stage 0

## Stage A-C

| Stage                  | Criteria                  | ECOG     |
| ---------------------- | ------------------------- | -------- |
| Early stage (A)        | 1 HCC or 3 nodules â‰¤ 3 cm | ECOG 0   |
| Intermediate stage (B) | Multinodular              | ECOG 0   |
| Advanced stage (C)     | Portal invasion, N1, M1   | ECOG 1/2 |

## Stage D: End stage
